Regulatory Shifts Will Pressure Diagnostics Yet Spur Measured Turnaround
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 16 Analysts
Published
20 Apr 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
US$100.00
9.2% undervalued intrinsic discount16 Aug
US$90.78
1Y
-24.5%7D
5.8%